You Searched For "moderna therapeutics" and got 20 results
Sort By:
1 min read
The 10 people transforming healthcare, from companies like Moderna, Humana, and Lexeo Therapeutics
Insider has released its 2022 list of 100 people who are transforming business across different sec…
Business Insider
1 min read
Meet Moderna's cofounder and chairman, whose coronavirus vaccine could roll out nationwide as soon as this weekend. He loves basketball and Dolly Parton.
Ahead of the Moderna vaccine's presumptive authorization, Business Insider spoke with Afeyan about …
Juliana Kaplan
3 mins read
Moderna soars 18% after early coronavirus vaccine trial produces antibodies in all patients
A range of dosages induced immune responses and were "generally safe and well-tolerated," Moderna s…
Ben Winck
2 mins read
A Harvard medical professor is now a billionaire after his early stake in Moderna soared 17,000%
Timothy Springer invested $5 million in the biotech company early on, and his stake has since swell…
Ben Winck
2 mins read
Adagio Therapeutics extends 3-day gain to 319% on hopes that its antiviral can treat the Omicron variant
"ADG20 was uniquely designed to combine breadth, potency and duration of protection against SARS-Co…
Matthew Fox
2 mins read
Moderna, BioNTech, and Novavax plunge after President Biden says the COVID-19 pandemic 'is over'
"The pandemic is over. We still have a problem with COVID. We're still doing a low of work on it. B…
Matthew Fox
3 mins read
Indian origin scientist named as the primary contributor to invention of Moderna's COVID-19 vaccine
He is also listed as one of the inventors in two other Covid-19 vaccine patent applications by…
1 min read
Moderna spikes 11% to record highs after it is selected to be added to S&P 500
Alexion Therapeutics, which is set to be acquired by AstraZeneca, will be replaced by Moderna in th…
Matthew Fox
3 mins read
Booster shots of COVID-19 vaccine probably won't cause worse side effects than the original vaccines, experts predict
Moderna, Pfizer and AstraZeneca's COVID-19 booster shot trials will provide more information about …
Dr. Catherine Schuster-Bruce
1 min read
Moderna slumps 11% as the vaccine-maker's Q1 revenue misses estimates
The pharma company's full-year sales forecast for its vaccine was raised to $19.2 billion, up from …
Shalini Nagarajan
2 mins read
Silicon Valley healthcare startups can face pitfalls
These are Insider's biggest healthcare stories for March 29.
Shelby Livingston
28 mins read
The CEO of Moderna on the moment he first realized the company could make a COVID-19 vaccine
In a recent Andreessen Horowitz podcast, Stéphane Bancel discusses how mRNA works and why it's tran…
Jorge Conde, Hanne Winarsky, …
2 mins read
Wall Street digs into the timeline for Moderna's coronavirus shot
These are the top stories written by Business Insider's healthcare team for August 4.
Andrew Dunn
2 mins read
Europe and Canada are facing temporary hits to coronavirus vaccine supply while Pfizer renovates a Belgian plant to eventually produce more doses
The renovation will impact shipments for about the next month, a Pfizer spokesperson told Insider, …
Andrew Dunn
5 mins read
Here are the common side effects you should expect if you get Moderna's coronavirus shot
Moderna vaccine has no major safety concerns but causes temporary, expected side effects for most p…
Andrew Dunn
7 mins read
COVID-19 vaccines are now being administered in the UK and US, but the rollout may take years in poorer countries. Here are the major challenges they face.
For low-income and developing countries, widespread access to a COVID-19 vaccine could come as late…
Grace Dean
6 mins read
Scientists are aiming to launch a nationwide trial as soon as possible to find out if the top coronavirus vaccines can stop the virus from spreading
We know the top vaccines can prevent people from getting sick with COVID-19. But we don't know whet…
Andrew Dunn
2 mins read
Moderna Therapeutics, a biotech unicorn valued at more than $7.5 billion, could be gearing up for an IPO as early as this winter
Moderna is currently engaged in strategic relationships with AstraZeneca, Merck, and Vertex Pharmac…
Charlotte Hu
3 mins read
It'll take weeks to vet a COVID-19 vaccine
These are Business Insider's biggest healthcare stories for November 17.
Lydia Ramsey Pflanzer
3 mins read
Moderna's promising coronavirus vaccine is a major beneficiary of the Trump administration's Operation Warp Speed
The government granted Moderna nearly $1 billion to support vaccine developments and committed $1.5…